{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:01:16Z","timestamp":1793736076056,"version":"4.6.1"},"reference-count":83,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2644761","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:40:04Z","timestamp":1774633204000},"page":"1027-1045","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025\/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States"],"prefix":"10.1080","volume":"29","author":[{"given":"Alon","family":"Yehoshua","sequence":"first","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-7331","authenticated-orcid":false,"given":"Manuela","family":"Di Fusco","sequence":"additional","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby E.","family":"Rudolph","sequence":"additional","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thoburn","sequence":"additional","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago M. C.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Dodd","sequence":"additional","affiliation":[{"name":"Evidera Inc.","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Yarnoff","sequence":"additional","affiliation":[{"name":"Evidera Inc.","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Centers for Disease Control and Prevention. 2025. Preliminary estimates of COVID-19 burden for 2024-2025. Available from: https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden-estimates.html"},{"key":"e_1_3_6_3_1","unstructured":"Centers for Disease Control and Prevention. 2025. Preliminary estimated flu disease burden 2024-2025 flu season. Available from: http:\/\/cdc.gov\/flu-burden\/php\/data-vis\/2024-2025.html"},{"key":"e_1_3_6_4_1","unstructured":"Centers for Disease and Control Prevention. COVID data tracker variant proportions. 2023. Available from:https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.01.024"},{"key":"e_1_3_6_6_1","unstructured":"FDA. 2024. Updated COVID-19 vaccines for use in the United States Beginning in Fall 2024."},{"key":"e_1_3_6_7_1","unstructured":"FDA. COVID-19 vaccines (2025-2026 formula) for use in the United States beginning in fall 2025 [updated 2025 May 22]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/industry-biologics\/covid-19-vaccines-2025-2026-formula-use-united-states-beginning-fall-2025?utm_source=chatgpt.com"},{"key":"e_1_3_6_8_1","unstructured":"FDA. Comirnaty. 2025. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/comirnaty"},{"key":"e_1_3_6_9_1","unstructured":"CDC. Staying up to date with COVID-19 vaccines. 2025 [updated November 19]. Available from: https:\/\/www.cdc.gov\/covid\/vaccines\/stay-up-to-date.html"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2071427"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2429335"},{"key":"e_1_3_6_12_1","unstructured":"Centers for Disease Control and Prevention. 2021. Science brief: SARS-CoV-2 infection-induced and vaccine-induced immunity [updated October 29]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/vaccine-induced-immunity.html"},{"key":"e_1_3_6_13_1","unstructured":"Jarvis L. Covid Boosters Like Flu Shots Need a Yearly Schedule. Bloomberg.com. Available from: https:\/\/www.bloomberg.com\/opinion\/articles\/2022-06-01\/covid-boosters-like-flu-shots-need-a-yearly-schedule?leadSource=uverify%20wall."},{"key":"e_1_3_6_14_1","unstructured":"Stoecker C. Economic Assessment of Routine PCV20 for Children. ACIP Meeting June 22 20232023."},{"key":"e_1_3_6_15_1","unstructured":"Leidner AJ Chesson HW Meltzer MI et al. Guidance for health economics studies presented to the advisory committee on immunization practices (ACIP) 2019 update. 2019. https:\/\/www.cdc.gov\/vaccines\/acip\/committee\/downloads\/Economics-Guidance-for-ACIP-2019.pdf"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.008"},{"key":"e_1_3_6_18_1","unstructured":"Our World in Data. COVID-19 vaccine doses administered by manufacturer United States (Sept 2022 - March 2023). Available from: https:\/\/ourworldindata.org\/grapher\/covid-vaccine-doses-by-manufacturer?time=2022-09-02.2024-03-31&country=\u223cUSA"},{"key":"e_1_3_6_19_1","unstructured":"CDC. COVIDVaxView. Adults 18+ COVID-19 vaccination coverage and intent [updated 2025 May 7]. Available from: https:\/\/www.cdc.gov\/covidvaxview\/weekly-dashboard\/adult-vaccination-coverage.html"},{"key":"e_1_3_6_20_1","unstructured":"Centers for Disease Control and Prevention. Rates of COVID-19 cases or deaths by age group and updated (bivalent) booster status [updated 2023 Jun 1]. Available from: https:\/\/data.cdc.gov\/Public-Health-Surveillance\/Rates-of-COVID-19-Cases-or-Deaths-by-Age-Group-and\/54ys-qyzm\/about_data"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd22.240539"},{"key":"e_1_3_6_22_1","unstructured":"Centers for Disease and Control Prevention. 2022. Estimated COVID-19 Burden 2022. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/burden.html"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2811.221109"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25320"},{"key":"e_1_3_6_25_1","unstructured":"Centers for Disease Control and Prevention. 2025. About reinfection [updated 2024 Jun 14]. Available from: https:\/\/www.cdc.gov\/covid\/about\/reinfection.html"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofag019"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0750"},{"key":"e_1_3_6_28_1","unstructured":"Klein NP Shimabukuro T. Safety update of 1st booster mRNA COVID-19 vaccination. 2025 [updated 2022 Apr 20]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/116526"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0600"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020118"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.7179"},{"key":"e_1_3_6_32_1","unstructured":"Centers for Disease Control and Prevention. COVID-NET laboratory-confirmed COVID-19 hospitalizations. 2025. Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#covidnet-hospitalization-network"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2416873"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7232a2"},{"key":"e_1_3_6_35_1","unstructured":"Centers for Medicare and Medicaid Services. Medicare administrative contractor (MAC) COVID-19 test pricing 2022. Available from: https:\/\/www.cms.gov\/files\/document\/mac-covid-19-test-pricing.pdf"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2037917"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.078"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.364"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6945e2"},{"key":"e_1_3_6_40_1","unstructured":"Bureau Of Labor Statistics US. Labor force statistics from the current population survey. 2025. Available from: https:\/\/www.bls.gov\/cps\/cpsaat03.htm."},{"key":"e_1_3_6_41_1","unstructured":"US Bureau of Labor Statistics. Table. Median usual weekly earnings of full-time wage and salary workers by age race Hispanic or Latino ethnicity and sex fourth quarter 2024 averages not seasonally adjusted. 2025. Available from: https:\/\/www.bls.gov\/news.release\/wkyeng.t03.htm"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-022-00528-w"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1081-5"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(00)00591-x"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14262"},{"key":"e_1_3_6_46_1","doi-asserted-by":"crossref","unstructured":"Sandmann F Tessier E Lacy J et al. Longterm health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: longitudinal analysis and cross-sectional comparison with controlsMedRxiv. 2021.","DOI":"10.1101\/2021.10.22.21264701"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017030"},{"key":"e_1_3_6_48_1","unstructured":"US Census Bureau. Annual estimates of the resident population by single year of age and sex for the United States. 2020 to July 1 2023 (NC-EST2023-AGESEX-RES); POPESTIMATE2023. April 1. Available from: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-national-detail.html"},{"key":"e_1_3_6_49_1","unstructured":"CDC. Underlying conditions and the higher risk for severe COVID-19 [updated 2025 Feb 6]. Available from: https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad796"},{"key":"e_1_3_6_51_1","unstructured":"Centers for Disease Control and Prevention (CDC). Reinfections and COVID19. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/reinfection.html"},{"key":"e_1_3_6_52_1","unstructured":"Klein NP Shimabukuro T. Safety update of 1st booster mRNA COVID-19 vaccination. 2022. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2022-04-20\/03-COVID-Klein-Shimabukuro-508.pdf"},{"key":"e_1_3_6_53_1","unstructured":"Pfizer. 2023. Comirnaty label."},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0470"},{"key":"e_1_3_6_55_1","unstructured":"US Census Bureau. Population and housing unit estimates. 2025 [updated 2025 Mar 4]. Available from: https:\/\/www.census.gov\/programs-surveys\/popest.html"},{"key":"e_1_3_6_56_1","unstructured":"Centers for Disease Control and Prevention. COVID-19\u2013Associated Hospitalizations\u2014COVID-NET. 2025. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/03-Havers-COVID-508.pdf"},{"key":"e_1_3_6_57_1","unstructured":"CDC. Long COVID basics. 2025. https:\/\/www.cdc.gov\/long-covid\/about\/index.html"},{"key":"e_1_3_6_58_1","unstructured":"Centers for Medicare & Medicaid Services. 2023. Search the physician fee schedule (CPT 90471). Available from: https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search?Y=0&T=0&HT=0&CT=3&H1=90471&M=5"},{"key":"e_1_3_6_59_1","unstructured":"CDC. 2025. Current CDC vaccine price list. https:\/\/www.cdc.gov\/vaccines-for-children\/php\/awardees\/current-cdc-vaccine-price-list.html"},{"key":"e_1_3_6_60_1","unstructured":"Agency for Healthcare Research and Quality. 2022. Healthcare cost and utilization project (HCUPnet). Available from: https:\/\/datatools.ahrq.gov\/hcupnet"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13212704"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11202790"},{"key":"e_1_3_6_63_1","unstructured":"Centers for Disease Control and Prevention. 2019. Guidance for health economics studies presented to the advisory committee on immunization practices (ACIP) [updated October 11]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/committee\/downloads\/Economics-Guidance-for-ACIP-2019.pdf"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01222-6"},{"key":"e_1_3_6_65_1","unstructured":"Whittington MD Campbell JD. Alternative pricing models for remdesivir and other potential treatments for COVID-19. Boston MA: Institute for Clinical and Economic Review [updated 2020 Jun 24]. Available from: https:\/\/collections.nlm.nih.gov\/catalog\/nlm:nlmuid-101769591-pdf"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1965732"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454579"},{"key":"e_1_3_6_69_1","unstructured":"Prosser LAHD Gebremariam A Rose A et al. Economic analysis of the COVID-19 vaccine. Presented at the June 27 2024 Meeting of the Advisory Comittee on Immunization Practices; 2024."},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2024.02.007"},{"key":"e_1_3_6_72_1","first-page":"ofad233","volume-title":"Systematic review of the prevalence of long COVID","author":"Woodrow M","year":"2023","unstructured":"Woodrow M, Carey C, Ziauddeen N, et al. Systematic review of the prevalence of long COVID. Oxford University Press US; 2023. ofad233."},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac136"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300570"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad658"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20251"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.04.453"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1242541"},{"key":"e_1_3_6_79_1","unstructured":"University of Michigan COVID-19 Vaccination Modeling Team. Economic analysis of COVID-19 vaccination: presentation to the Advisory Committee on Immunization Practices. 2025. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-09-18-19\/08-Srinivasan-covid-508.pdf"},{"key":"e_1_3_6_80_1","unstructured":"Stoecker C. Economic Assessment of PCV20 for Adults Vaccinated with PCV13: presented at ACIP October 19 2022. 2022. Available from: https:\/\/archive.cdc.gov\/#\/details?url=https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2022-10-19-20.html"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020190"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/rsp3.12372"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.07.002"},{"key":"e_1_3_6_84_1","unstructured":"Centers for Disease Control and Prevention (CDC). Rates of COVID-19 cases or deaths by age group and updated (bivalent) booster status. 2024. Available from: https:\/\/data.cdc.gov\/Public-Health-Surveillance\/Rates-of-COVID-19-Cases-or-Deaths-by-Age-Group-and\/54ys-qyzm\/about_data"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2644761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:40:19Z","timestamp":1774633219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2644761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2644761"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2644761","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}